Skip to main content
. 2014 Jun 24;9(6):e101022. doi: 10.1371/journal.pone.0101022

Figure 3. Expression of IGF2R and PPARGC1A is increased in donor cells treated with VPA.

Figure 3

The amounts of IGF2R (A), POU5F1 (B) and PPARGC1A (C) transcripts are expressed in relation to the control group. The asterisk (*) denotes difference between control and VPA-treated groups (P<0.0001).